基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 医药中间体 原料药中间体 辰辉创聚生物NEBULABIO 抗体偶联药物(ADC) 辰辉创聚生物Nebulabio 抗体偶联药物(ADC)
  • 辰辉创聚生物Nebulabio 抗体偶联药物(ADC)

辰辉创聚生物Nebulabio 抗体偶联药物(ADC) 新品

询价 1件 起订
北京 更新日期:2024-12-30

维百奥(北京)生物科技有限公司

VIP3年
联系人:王经理
手机:13691409741 拨打
邮箱:info@vicbio.com

产品详情:

中文名称:
辰辉创聚生物Nebulabio 抗体偶联药物(ADC)
品牌:
Nebulabio
产品类别:
辰辉创聚生物Nebulabio

加logo.png

维百奥生物代理辰辉创聚生物®Nebulabio- 抗体偶联药物(ADC)



| 产品概述

辰辉创聚生物®Nebulabio 深耕 ADC 小分子领域多年,主要提供 ADC 药物小分子以及 ADC 偶联定制服务,拥有 80多种库存现货产品。

ADC药物是采用特定的连接子将抗体和小分子细胞毒药物连接起来,其主要组成成分包括 抗体、连接子和小分子细胞毒药物(smallmolecular cytotoxic drug,SM)。抗体分子主要发挥靶向投递 作用,小分子药物发挥效应。但有些抗体同时存在 抗肿瘤的药效学作用,如Kadcyla中阿多曲妥珠单抗(ado-trastuzumab)和美坦新(maitansine)(美登素)存在协同作用。


| 系列产品

目录号品名物种靶点表达细胞系
NBR-1000Anti-ALCAM / CD166 Reference Antibody (Praluzatamab-MMAE)HumanALCAM / CD166CHO
NBR-1001Anti-AMHR2 Reference Antibody (Murlentamab-MMAE)HumanAMHR2CHO
NBR-1002Anti-AXL / UFO Reference Antibody (Enapotamab vedotin)HumanAXL / UFOCHO
NBR-1003Anti-AXL / UFO Reference Antibody (Tilvestamab-MMAE)HumanAXL / UFOCHO
NBR-1004Anti-MUC16 Reference Antibody (oregovomab-MMAE)HumanCA125 / MUC16CHO
NBR-1005Anti-MUC16 Reference Antibody (Sofituzumab vedotin)HumanCA125 / MUC16CHO
NBR-1006Anti-CA9 / CAIX Reference Antibody (girentuximab-MMAE)HumanCA9 / Carbonic anhydrase 9CHO
NBR-1007Anti-CD19 Reference Antibody (denintuzumab-MMAF)HumanCD19CHO
NBR-1008Anti-CD79b Reference Antibody (Polatuzumab vedotin-piiq)HumanCD79bCHO
NBR-1009Anti-CD79b Reference Antibody (iladatuzumab vedotin)HumanCD79bCHO
NBR-1010Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan)HumanCEACAM5 / CEA / CD66eCHO
NBR-1011Anti-CEACAM5 / CEA / CD66e Reference Antibody (Tusamitamab-MMAE)HumanCEACAM5 / CEA / CD66eCHO
NBR-1012Anti-CLDN18.2 Reference Antibody (zolbetuximab MMAE)
CLDN18.2CHO
NBR-1013Anti-CXCR4/CD184 Reference Antibody (ulocuplumab-MMAE)HumanCXCR4 / CD184CHO
NBR-1014Anti-DLL3 Reference Antibody (rovalpituzumab-MMAE)HumanDLL3CHO
NBR-1015Anti-Endoglin / CD105 Reference Antibody (carotuximab-MMAE)HumanEndoglin / CD105CHO
NBR-1016Anti-ERBB1 / EGFR / HER1 Reference Antibody (depatuxizumab-MMAF)HumanERBB1 / EGFR / HER1CHO
NBR-1017Anti-ERBB1 / EGFR / HER1 Reference Antibody (Cetuximab-MMAE)HumanERBB1 / EGFR / HER1CHO
NBR-1018Anti-ERBB2 / HER2 / CD340 Reference Antibody (Disitamab vedotin)HumanERBB2 / HER2 / CD340CHO
NBR-1019Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab-MMAE)HumanERBB2 / HER2 / CD340CHO
NBR-1020Anti-ERBB3/ HER3 Reference Antibody (patritumab-MMAE)HumanERBB3 / HER3CHO
NBR-1021Anti-ERBB3/ HER3 Reference Antibody (Patritumab deruxtecan)HumanERBB3 / HER3CHO
NBR-1022Anti-FOLH1 / PSMA Reference Antibody (rosopatamab-MMAE)HumanFOLH1 / PSMACHO
NBR-1023Anti-FOLR1 / FRA Reference Antibody (farletuzumab-MMAE)HumanFOLR1 / FRACHO
NBR-1024Anti-FOLR1 / FRA Reference Antibody (mirvetuximab-MMAE)HumanFOLR1 / FRACHO
NBR-1025Anti-GD3 Reference Antibody (ecromeximab-MMAE)HumanGD3CHO
NBR-1026Anti-GPC3 / Glypican-3 Reference Antibody (Codrituzumab-MMAE)HumanGPC3 / Glypican-3CHO
NBR-1027Anti-GPNMB Reference Antibody (Glembatumumab vedotin)HumanGPNMBCHO
NBR-1028Anti-GUCY2C Reference Antibody (Indusatumab vedotin)HumanGUCY2CCHO
NBR-1029Anti-HGFR / c-Met Reference Antibody (Telisotuzumab vedotin)HumanHGFR / c-MetCHO
NBR-1030Anti-IL-3Ra / CD123 Reference Antibody (talacotuzumab-MMAE)HumanIL-3Ra / CD123CHO
NBR-1031Anti-KAAG1 Reference Antibody (ADCT-901-MMAE)HumanKAAG1CHO
NBR-1032Anti-LIV-1 / SLC39A6 Reference Antibody (Ladiratuzumab vedotin)HumanLIV-1 / SLC39A6CHO
NBR-1033Anti-Mesothelin Reference Antibody (anetumab-MMAE)HumanMesothelinCHO
NBR-1034Anti-MU5AC Reference Antibody (ensituximab-MMAE)HumanMU5ACCHO
NBR-1035Anti-MUC1 Reference Antibody (clivatuzumab-MMAE)HumanMUC1CHO
NBR-1036Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin)HumanNaPi2b / SLC34A2CHO
NBR-1037Anti-NCAM1 / CD56 Reference Antibody (lorvotuzumab-MMAE)HumanNCAM1 / CD56CHO
NBR-1038Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)HumanNectin-4CHO
NBR-1039Anti-ROR1 Reference Antibody (Zilovertamab vedotin)HumanROR1CHO
NBR-1040Anti-ROR2 Reference Antibody (ozuriftamab vedotin)HumanROR2CHO
NBR-1041Anti-Siglec-2 / CD22 Reference Antibody (Pinatuzumab vedotin)HumanSiglec-2 / CD22CHO
NBR-1042Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab-MMAE)HumanSiglec-2 / CD22CHO
NBR-1043Anti-SLITRK6 Reference Antibody (Sirtratumab vedotin)HumanSLITRK6CHO
NBR-1044Anti-TF / Factor III / Tissue Factor / CD142 Reference Antibody (tisotumab vedotin)HumanTF / Factor III / Tissue Factor / CD142CHO
NBR-1045Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)HumanTNFRSF8 / CD30CHO
NBR-1046Anti-TNFSF7 / CD27L / CD70 Reference Antibody (Vorsetuzumab mafodotin)HumanTNFSF7 / CD27L / CD70CHO
NBR-1047Anti-TROP2 Reference Antibody (datopotamab deruxtecan)HumanTROP2CHO
NBR-1048Anti-TROP2 Reference Antibody (Sacituzumab-MMAE)HumanTROP2CHO







Nebulabio;抗体偶联药物;ADC;

公司简介

维百奥(北京)生物科技有限公司成立于2014年,经过多年的发展,已成为一家集生产、销售、代理、咨询为一体的,具有完备的生产、研发、技术支持能力,优异的售前售后服务的高新技术公司。致力于为生命科学、制药、诊断、化工、材料、食品、环境、检测等行业的企业,提供仪器、耗材、试剂、设备、服务的一站式服务。 公司经营范围涵盖分子生物学试剂、免疫学试剂、细胞生物学试剂、蛋白质研究试剂、微生物学试剂、化学及生化试剂、材料学试剂、天然提取物、仪器设备等9大门类,累计约10万余种产品,充分满足不同客户的个性化需求;公司代理国外50余种一线品牌试剂,以“高性价比、迅捷的物流速度、专业的技术支持”,让客户充分享受全球化带来的便利;公司还增加了基因编辑、蛋白表达、细胞鉴定等定制项目,大大提升了为客户服务能力。“不忘初心,方得始终”,维百奥生物将继续秉持“专心、专业、为您”的宗旨,以客户为根本,以诚信为基础,持续地为各界客户提供更加优质的产品和服务。

成立日期 (11年)
注册资本 300万人民币
员工人数 10-50人
年营业额 ¥ 1000万-5000万
经营模式 贸易,工厂,试剂,定制,服务
主营行业 化学试剂

辰辉创聚生物Nebulabio 抗体偶联药物(ADC)相关厂家报价 更多

内容声明
拨打电话 立即询价